With the increasing prevalence of neoplasia and kidney disease, patients undergoing oncological treatment are at greater risk of acute renal failure. Joint oncological and nephrological management requires a thorough understanding of the patient's clinical history, as well as the potential nephrotoxic effects of chemotherapy and immunotherapy. This article proposes a comprehensive approach to the assessment of acute renal failure in patients undergoing treatment for neoplasia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.53738/REVMED.2024.20.863.425 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!